Analysis reveals that stage at diagnosis affects mortality in non-affective psychoses, suggesting care gaps.
Our findings suggest that a relatively small proportion of the effect of NAPD on mortality is mediated by stage at diagnosis, while time to treatment initiation does not mediate that effect. This excess risk is potentially mediated by other patient, provider, and system-related factors in cancer care.
No takes yet. Share an insight, caveat, or question.
Wootten et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: